Trials / Completed
CompletedNCT01138774
Effects of Lipoic Acid and Eicosapentaenoic Acid (EPA) in Human Obesity
Cellular and Molecular Effects of Lipoic Acid and Eicosapentaenoic Acid (EPA) on Adipose Tissue: Potential Application in Human Obesity
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 103 (actual)
- Sponsor
- Clinica Universidad de Navarra, Universidad de Navarra · Academic / Other
- Sex
- Female
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to analyze the effects of Lipoic acid and/or EPA supplementation on weight loss, lipid profile, insulin resistance, oxidative and inflammation parameters, metabolomic profile as well as on adipose tissue gene profile in healthy overweight/obese subjects following an energy-restricted diet.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Double blind dietary intervention with EPA and lipoic acid | Placebo-controlled dietary intervention during 10 weeks. All groups will have a dietary treatment with a calorie restriction of 30 % the subject's energy expenditure at baseline, supplemented with eicosapentaenoic acid (EPA) and/or lipoic acid (LA). |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2011-12-01
- Completion
- 2012-12-01
- First posted
- 2010-06-07
- Last updated
- 2015-05-28
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01138774. Inclusion in this directory is not an endorsement.